Skip to content

Vitamin D Level and Risk of Infections in Cirrhotic Patients

Vitamin D Level and Risk of Infections in Cirrhotic Patients: Does it Have a Role?

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03391245
Enrollment
87
Registered
2018-01-05
Start date
2017-08-01
Completion date
2018-02-15
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection, Liver Cirrhosis, Vitamin D Deficiency

Brief summary

It is widely known that vitamin D has an important role in calcium metabolism and bone mineralization. Its deficiency is related to rickets and osteomalacia in children and adults respectively. Vitamin D had a role in innate and acquired immunity. It increases innate defense and modulates lymphocytes activation, leading to a change toward a T2 helper response ). The role of vitamin D deficiency on the risk of bacterial infection among patients in intensive care units has been reported. An observational studies in children reported an association between low 25-OH vitamin D level and infectious viral diseases . The deranged metabolism of vitamin D in liver cirrhosis was first reported in the late '70s and was attributed mainly to impaired 25(OH)-vitamin D hydroxylation of the precursor vitamin D caused by impaired liver function. Low level of vitamin D was found independently to be associated with increased risk of bacterial infections in patients with liver cirrhosis. The observed relationship between the lack of vitamin D and the increase risk of mortality in cirrhotic patients could be attributed to bacterial infections. Thus, the association of low vitamin D levels with liver insufficiency and infections supports the use of vitamin D as a prognostic marker in the population of cirrhosis. Studies on the role of vitamin D as a risk factor for infections in patients with liver cirrhosis are not well studied in our locality(Upper Egypt).

Interventions

DIAGNOSTIC_TEST3- Serum 25-Hydroxy Vitamin D level will be measured by Competitive ELISA technique

Serum 25-Hydroxy Vitamin D level will be measured by Competitive ELISA technique using CALBIOTECH (A life science company) kit, Catalog No.: VD220B

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted patients with liver cirrhosis irrespective of the underlying etiology during 6 months in Al Rajhi Liver Hospital, Assiut, Egypt who accept to participate in the study

Exclusion criteria

* Patients with cholestatic liver disease, patients receiving antibiotics to treat their infection prior hospital admission and patients refusing to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Vitamin D deficiency as a risk factor for infection in cirrhotic patients6 monthMeasurement of Vitamin D levels in cirrhotic with infection when compared with cirrhotic without infection and determination of Vitamin D level cut-off points for infection in cirrhotic patients

Secondary

MeasureTime frameDescription
Correlation of Vitamin D level with Liver Disease severity6 monthCorrelation of Vitamin D level with Child Pugh Grade
Correlation of vitamin D level with liver disease severity6 monthCorrelation of Vitamin D level with MELD score
Determination of independent predictor of infection in cirrhotics6 monthUse of logistic regression analysis for risk factors for infection in cirrhotic patients

Countries

Egypt

Contacts

Primary ContactHaidi K Ramadan, M.D
Heidi_ramadan@yahoo.com00201005091937

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026